Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Peptide 144 TGF- ▀1 inhibitor (TSLDASIIWAMMQN)

EU orphan designation number: EU/3/05/329   
Active ingredient: Peptide 144 TGF- ▀1 inhibitor (TSLDASIIWAMMQN)
Indication: Treatment of the localised scleroderma
Sponsor: Digna Biotech S.L.
Avenida Pio XII, 22, oficina 2, E-31008 Pamplona, Navarra, Espa˝a

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/11/2005 Centralised Orphan - Designation EMEA/OD/081/05 (2005)4363 of 28/10/2005
01/02/2007 Other procedure
22/06/2010 Other procedure EMEA/OD/081/05